News from itus corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 28, 2018, 07:00 ET ITUS Corporation Changing Company Name to Anixa Biosciences and Stock Ticker Symbol to ANIX

ITUS Corporation (the "Company") (NASDAQ: ITUS), a biotechnology company focused on using the body's immune system to fight cancer, today announced...


Sep 05, 2018, 11:55 ET Moffitt Cancer Center and ITUS Corporation Announce Scheduling of Pre-IND Meeting with the FDA for their CAR-T Therapy

ITUS Corporation (NASDAQ: ITUS) and its research partner, Moffitt Cancer Center, today announced that a pre-IND meeting with the US FDA has been...


Aug 17, 2018, 07:00 ET ITUS Corporation to Present at Next Generation Dx Summit

ITUS Corporation (NASDAQ: ITUS) today announced that CEO, Dr. Amit Kumar, will be presenting at the Next Generation Dx Summit in Washington, D.C.,...


Aug 01, 2018, 07:00 ET Moffitt Cancer Center and ITUS Corporation Request Meeting with FDA Regarding Ovarian Cancer CAR-T Therapy

ITUS Corporation (NASDAQ: ITUS) today announced that it and its research partner, Moffitt Cancer Center, have requested a meeting with the US FDA to...


Jul 30, 2018, 07:00 ET ITUS Corporation Releases Results for Cchek™ Breast Cancer Study

ITUS Corporation (NASDAQ: ITUS) today announced that it has released interim data from a breast cancer study using its Cchek™ non-invasive (utilizing ...


Jul 06, 2018, 08:00 ET ITUS Corporation Announces Second Commercial Focus for Cchek™ will be Breast Cancer

ITUS Corporation (NASDAQ: ITUS) today announced that due to the significance of positive results as well as strong commercial interest, it has...


Jun 29, 2018, 08:00 ET ITUS to Ring the NASDAQ Closing Bell on July 5th

ITUS Corporation (NASDAQ: ITUS) today announced that it has been invited by NASDAQ to ring the closing bell on July 5, 2018. ITUS CEO, Dr. Amit Kumar ...


Jun 26, 2018, 08:00 ET ITUS Accelerates Schedule for its CAR T Therapy and Provides Update

ITUS Corporation (NASDAQ: ITUS) today provided a status update and accelerated development timeline for its CAR T therapy for Ovarian Cancer, which...


Jun 13, 2018, 08:00 ET ITUS Corporation Announces First Commercial Focus for Cchek™ will be Prostate Cancer

ITUS Corporation (NASDAQ: ITUS) today announced that it has chosen prostate cancer as the first commercial focus for its Cchek™, non-invasive liquid...


Apr 02, 2018, 07:00 ET ITUS Presentation to Special Meeting of Stockholders

ITUS Corporation (NASDAQ: ITUS) today announced that the presentation given by its Chief Executive Officer, Dr. Amit Kumar, at its Special Meeting of ...


Mar 27, 2018, 07:00 ET ITUS and Serametrix Announce Results of a Blinded Prostate Cancer Study

ITUS Corporation (NASDAQ: ITUS) today announced that it has completed a prostate cancer study with Serametrix in which data from a previous...


Mar 26, 2018, 07:00 ET ITUS Announces Issuance of Second Key Cancer Detection Technology Patent

ITUS Corporation (NASDAQ: ITUS), a company using the power of the immune system to diagnose and treat cancer, today announced that the United States...


Mar 16, 2018, 07:00 ET ITUS to Present Data from Early Cancer Detection Study Utilizing Artificial Intelligence at the American Association of Immunologists (AAI) Meeting

ITUS Corporation (NASDAQ: ITUS), today announced that it will present the latest data from its ongoing early cancer detection study at the annual...


Mar 12, 2018, 07:00 ET ITUS will Present Data at the American Association of Cancer Research (AACR) Annual Meeting

ITUS Corporation (NASDAQ: ITUS), today announced that it will present data from its ongoing study utilizing Cchek™, ITUS's artificial intelligence...


Mar 09, 2018, 07:00 ET ITUS Corporation to Present at the 2018 Inaugural China Healthcare Investment & Partnering Symposium (CHIPS)

ITUS Corporation (NASDAQ: ITUS) today announced that John Roop, Senior Vice President of Engineering is scheduled to present on Friday March 16,...


Mar 05, 2018, 07:00 ET ITUS Corporation Forms Alliance with Serametrix Corporation

ITUS Corporation (NASDAQ: ITUS) today announced that ITUS and Serametrix Corporation have signed an agreement to bring the power of Cchek™, ITUS's...


Feb 07, 2018, 07:00 ET ITUS will Present Artificial Intelligence Powered Early Cancer Detection Technology at the Keystone Symposia Conference - Cancer Immunotherapy: Combinations

ITUS Corporation (NASDAQ: ITUS), today announced that its presentation titled, "The coupling of MDSCs with a computational analytic method to detect...


Jan 29, 2018, 07:00 ET ITUS Presents Positive Data from its Early Cancer Detection Technology at ASCO-SITC Symposium

ITUS Corporation (NASDAQ: ITUS), today announced that it presented positive data from its early cancer detection technology on January 26th at the...


Jan 22, 2018, 07:00 ET ITUS Will Present Early Cancer Detection Data at ASCO-SITC Symposium on January 26

ITUS Corporation (NASDAQ: ITUS), today announced again that it will be presenting data on its early cancer detection technology on January 26th at...


Dec 12, 2017, 06:00 ET ITUS Corporation Terminates At-The-Market Offering

ITUS Corporation (NASDAQ: ITUS), announced today that it has terminated its at-the-market equity program ("ATM Offering") with B. Riley FBR, Inc. The ...


Dec 06, 2017, 06:00 ET ITUS Will Present Data on Early Cancer Detection Technology at ASCO-SITC Symposium

ITUS Corporation (NASDAQ: ITUS) today announced that its abstract titled, "The coupling of MDSCs with a computational analytic method to detect solid ...


Nov 28, 2017, 06:00 ET ITUS Receives Notice of Allowance for Second Key Cancer Technology Patent

ITUS Corporation (NASDAQ: ITUS), a company using the power of the immune system to diagnose and treat cancer, today announced that the United States...


Nov 22, 2017, 06:00 ET ITUS Conference Call Recording Available on Company Website

ITUS Corporation (NASDAQ: ITUS) today announced that it has made available at www.ituscorp.com, the recording of its November 21, 2017 conference...


Nov 21, 2017, 11:25 ET ITUS Will Hold Conference Call to Discuss its CAR-T Cancer Therapeutics Program

ITUS Corporation (NASDAQ: ITUS) reminds interested parties that it will be holding a conference call today at 2 p.m. Pacific/5 p.m. Eastern to...


Nov 20, 2017, 06:00 ET ITUS Enters CAR-T Research Alliance with Moffitt Cancer Center

ITUS Corporation (NASDAQ: ITUS) today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with Moffitt Cancer ...